Healthcare -
Biotechnology - NASDAQ - US
$ 6.43
-2.43 %
$ 2.47 B
Market Cap
-3.8
P/E
Price Target
Average
74.96%
Revenue Forecast
Estimate
63.35%
EBIT
Estimate
17.82%
Net Income
Estimate
15.57%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Recursion Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for RXRX of $11.2 , with forecasts ranging from
a
low of
$6 to a high of $16 .
RXRX Lowest Price Target
Wall Street Target
6 USD
-6.69%
RXRX Average Price Target
Wall Street Target
11.2 USD
74.96%
RXRX Highest Price Target
Wall Street Target
16 USD
148.83%
REVENUE FORECAST
Revenue Forecast Chart RXRX
EBIT FORECAST
EBIT Forecast Chart RXRX
NET INCOME FORECAST
Net Income Chart RXRX